Skip to main content
. 2019 Sep 11;37(31):2846–2856. doi: 10.1200/JCO.19.00640

TABLE A2.

Clinical Characteristics and Outcome Stratified by Low-, Intermediate-, and High-Risk Groups According to the Mutation-Adjusted Risk Score (MARS) for Patients With Advanced Systemic Mastocytosis (including both training and validation sets)

graphic file with name JCO.19.00640ta2.jpg